News und Analysen
Humana Adds 14 States in Phase 2 of CenterWell Home Health Launch
Humana Inc. (NYSE: HUM) has announced the addition of 14 states to the ongoing initiative to rebrand the home health division of Kindred at Home (KAH) as CenterWell Home Health. The announcement of
Waters and University of Delaware Announce Official Opening of Immerse Delaware Lab
Waters Corporation (NYSE: WAT) and The University of Delaware announced the grand opening of Immerse™ Delaware, a new Waters innovation and research laboratory. As part of their multi-year research
Waters stellt Xevo TQ Absolute vor – das empfindlichste und kompakteste Tandem-Quadrupol-Massenspektrometer für den Tischeinsatz
Waters Corporation (NYSE:WAT) hat heute das neue System Xevo™ TQ Absolute vorgestellt, das empfindlichste und kompakteste Tandem-Massenspektrometer seiner Klasse für den Tischeinsatz.i
Diese
Waters Introduces Xevo TQ Absolute – The Most Sensitive and Compact Benchtop Tandem Quadrupole Mass Spectrometer
Waters Corporation (NYSE:WAT) today introduced the new Xevo™ TQ Absolute system, the most sensitive and compact benchtop tandem mass spec in its class.i
This press release features multimedia
Waters präsentiert eine schnellere, zuverlässigere und automatisierte Lösung für die Massen- und Reinheitsanalyse von Biomolekülen
Die Waters Corporation (NYSE:WAT) stellte heute neue Software und analytische Säulen zur Unterstützung der Erforschung und Entwicklung von Biomolekülen vor. Mit der neuen App 'Intact Mass' von
Waters Introduces Faster, Reliable and Automated Solution for Mass and Purity Analysis of Biomolecules
Waters Corporation (NYSE:WAT) today introduced new software and analytical columns to aid biomolecule drug discovery and development. The new Waters™ Intact Mass app on waters_connect™ allows
Humana Launches CenterWell Home Health
One year after launching the CenterWell brand to represent Humana’s payer-agnostic healthcare service offerings, Humana Inc. (NYSE: HUM) has started to transition Kindred at Home’s home health
Humana Earns Top Score in Human Rights Campaign Foundation’s 2022 Corporate Equality Index
Leading health insurer and health care services company Humana Inc. (NYSE: HUM), proudly announced that it received a score of 100 on the Human Rights Campaign Foundation’s 2022 Corporate Equality
Waters Earns Top Score in Human Rights Campaign Foundation’s 2022 Corporate Equality Index
Waters Corporation (NYSE:WAT) announced that it received a score of 100 on the Human Rights Campaign Foundation’s 2022 Corporate Equality Index (CEI), the nation’s foremost benchmarking survey and
Humana Foundation Names Tiffany Benjamin As Chief Executive Officer
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) has announced the appointment of Tiffany Benjamin as its new Foundation CEO, effective January 3, 2022.
This press release
Agilent Announces the Cary 3500 UV-Vis Spectrophotometer Compatibility with OpenLab
Agilent Technologies Inc. (NYSE: A) has announced that the Agilent Cary 3500 UV-Vis Spectrophotometer is now compatible with the Agilent OpenLab software suite of products. The Cary 3500 UV-Vis
Intuitive Surgical: Absolut überzeugend!
In den USA hat die Berichtssaison bereits begonnen, so dass derzeit ein Unternehmen nach dem anderen seine aktuellen Quartalszahlen vorlegt. Gestern Abend, nachbörslich, war nun der
Gilead Sciences: Wer wird nun der nächste Corona-Gewinner?
Auf dem US-Konzern Gilead Sciences (WKN: 885823) und dem Wirkstoff Remdesivir liegen die Hoffnungen vieler Anleger. Doch Medikamente und Impstoffe sind nicht die einzigen Corona-Profiteure.
Humana and Evergreen Nephrology Introduce New Specialized Care Program for Patients Living with Kidney Disease
Humana Inc. (NYSE: HUM), a leading health and well-being company, announced a new value-based kidney care program with Evergreen Nephrology designed to advance quality of care and help optimize
CenterWell Home Health Launches 20th Food Fundraising Drive
CenterWell Home Health, one of America’s largest home health providers, has launched its 20th annual Food Fundraising Drive, an effort to fight food insecurity in the communities it serves.
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with David Denton, Chief Financial Officer, Executive Vice President, at the Morgan
Pfizer Launches PfizerForAll™, a Digital Platform that Helps Simplify Access to Healthcare
Pfizer Inc. (NYSE: PFE) today introduced PfizerForAll, a user-friendly digital platform designed to make access to healthcare and managing health and wellness more seamless for people across the
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the U.S. Food and Drug Administration (“FDA”) has approved the supplemental Biologics License
Agilent Reports Third-Quarter Fiscal Year 2024 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.58 billion for the third quarter ended July 31, 2024, a decline of 5.6% reported and 4.4% core(1) compared to the third quarter of
Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the Wells Fargo Healthcare Conference on Thursday, Sept. 5, 2024.
Bernard Zovighian, chief executive officer
Inaugural Humana Community Day Promotes Health Benefits of Volunteerism
Several thousand green-shirted Humana employees will volunteer in Louisville on Aug. 21, marking the anniversary of the company’s founding, demonstrating Humana’s commitment to its hometown and
Humana Announces New Veteran Hiring Strategy and Recognition as Top Veteran-Friendly Company
Humana Inc. (NYSE: HUM), a leading health and well-being company, launches a refreshed military-connected hiring strategy and earns recognition by U.S. Veterans Magazine as a Top Veteran-Friendly
Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age
Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced top-line results from their Phase 3 clinical trial to evaluate the companies’ combined mRNA vaccine
Agilent Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance
Agilent Technologies Inc., (NYSE: A) today announced the release of its new Agilent J&W 5Q GC/MS Columns, representing a major advance in gas chromatography/mass spectrometry (GC/MS) column
Pfizer Announces Top-Line Results of ABRYSVO® for RSV in Immunocompromised Adults
Pfizer Inc. (NYSE: PFE) today announced positive top-line safety and immunogenicity results from substudy B of the ongoing pivotal Phase 3 clinical trial (NCT05842967) MONeT (RSV IMmunizatiON Study